Belgium· BE-AMP-SAM462657-00
Olysio 150 mg
A simeprevir product containing simeprevir sodium, registered in Belgium by Janssen-Cilag International.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Simeprevir Sodium
- Manufacturer
- Janssen-Cilag International
- Country
- Belgium (BE)
- ATC code
- J05AE14
- ATC class
- Simeprevir
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb3151008
- be_apb7709082
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
63 interactions on record for simeprevir.
Graded by severity as the source publishes them — 21 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Simeprevir · interactions on record
63 records
- 21 severe
- 40 moderate
- 2 minor
Most severe, free to view
- CisaprideA03FA02severe
- EluxadolineA07DA06severe
- EdoxabanB01AF03severe
- RosuvastatinC10AA07severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Simeprevir in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2d893ff2-97e7-4de9-9fc7-be4b041a9c8c GET /v1/drugs/2d893ff2-97e7-4de9-9fc7-be4b041a9c8c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"source": "afmps",
"status": "REVOKED",
"name_en": "Olysio 150 mg",
"name_fr": "Olysio 150 mg",
"name_nl": "Olysio 150 mg",
"amp_code": "SAM462657-00",
"strengths": [
"150.0000"
],
"pack_count": 2,
"substances": [
"Simeprevir Sodium",
"Simeprevir"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Simeprevir",
"authorisation_numbers": [
"EU/1/14/924/001",
"EU/1/14/924/002"
]
}See everything about simeprevir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.